Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : NTRA save search
Roelof Botha, Lead Independent Director of Natera Board, Makes $5 Million Investment in Natera
Published: 2022-03-16 (Crawled : 15:30) - prnewswire.com
NTRA S | $87.28 -3.38% -3.6% 1.2M
|
Health Services
|
| O: 3.66%
H: 11.52%
C: 11.42%
CareDx Wins $44.9M in Damages in False Advertising Trial Against Natera; Natera Intentionally Deceived Transplant Community
Published: 2022-03-15 (Crawled : 01:00) - globenewswire.com
NTRA S | $87.28 -3.38% -3.6% 1.2M
|
Health Services
|
| O: -18.24%
H: 0.8%
C: -2.98%
CDNA | $8.07 -2.54% -2.48% 670K
|
Health Technology
|
| O: 0.96%
H: 9.73%
C: 9.52%
als trial tiona
United States Hereditary Genetic Testing Markets,2022-2032: Technological Advancements for Exome Sequencing/Rise of Direct-to-Consumer (DTC) Testing Services Leading to Multi-Billion Opportunities
Published: 2023-01-11 (Crawled : 12:00) - prnewswire.com
TMO | News | $541.52 -1.05% -0.1% 1.8M
|
Health Technology
|
| O: 0.54%
H: 2.41%
C: 2.0%
DGX | $125.91 -0.84% 0.0% 870K
|
Health Services
|
| O: 0.24%
H: 0.6%
C: -0.04%
LH M | $199.45 -0.26% 0.0% 770K
|
Health Services
|
| O: 0.96%
H: 2.74%
C: 2.65%
NVTA | $0.019 0.0% 22M
|
Health Services
|
| O: 2.36%
H: 9.68%
C: 9.68%
A | $132.44 -1.57% 0.0% 1.6M
|
Health Technology
|
| O: 0.0%
H: 2.16%
C: 1.89%
NTRA S | $87.28 -3.38% -3.6% 1.2M
|
Health Services
|
| O: 0.66%
H: 9.53%
C: 8.55%
MYGN F | $18.51 -0.7% -0.7% 640K
|
Health Technology
|
| O: 0.0%
H: 8.08%
C: 6.7%
ILMN | $116.69 -1.35% -1.41% 1.6M
|
Health Technology
|
| O: 1.36%
H: 3.96%
C: 3.53%
FLGT | $20.11 0.1% 0.15% 220K
|
Health Services
|
| O: -0.03%
H: 2.44%
C: 2.11%
EXAS | $63.48 0.41% 0.36% 1.3M
|
Health Technology
|
| O: 0.68%
H: 11.09%
C: 11.07%
CNTG | $0.461 -3.96% -4.12% 23K
|
Commercial Services
|
| O: -0.02%
H: 1.04%
C: 1.04%
services genetic
Natera Selected for UnitedHealthcare's Preferred Laboratory Network
Published: 2022-07-14 (Crawled : 12:00) - prnewswire.com
NTRA S | $87.28 -3.38% -3.6% 1.2M
|
Health Services
|
| O: 0.52%
H: 9.98%
C: 7.37%
Foundation Medicine and Natera Announce Broad Clinical Launch and Medicare Coverage of FoundationOne®Tracker
Published: 2023-10-10 (Crawled : 13:30) - biospace.com/
NTRA S | $87.28 -3.38% -3.6% 1.2M
|
Health Services
|
| O: 0.07%
H: 7.13%
C: 6.62%
foundationone
Natera Announces Commercial Payor Coverage for Signatera™
Published: 2023-03-02 (Crawled : 14:00) - biospace.com/
NTRA S | $87.28 -3.38% -3.6% 1.2M
|
Health Services
|
| O: -2.21%
H: 7.27%
C: 6.39%
commercial
Global Liquid Biopsy Market Report 2022: Increased Awareness Regarding Cancer Boosts 13.77% Annual Growth
Published: 2022-11-08 (Crawled : 21:00) - prnewswire.com
BIO | News | $281.02 -3.38% 0.0% 370K
|
Health Technology
|
| O: -0.44%
H: 6.91%
C: 6.14%
NTRA S | $87.28 -3.38% -3.6% 1.2M
|
Health Services
|
| O: 3.06%
H: 0.43%
C: -15.25%
MYGN F | $18.51 -0.7% -0.7% 640K
|
Health Technology
|
| O: -0.78%
H: 5.43%
C: 3.08%
ILMN | $116.69 -1.35% -1.41% 1.6M
|
Health Technology
|
| O: -1.08%
H: 1.4%
C: 0.07%
BIOC | $0.4349 -10.32% 750K
|
Health Services
|
| O: -1.24%
H: 3.8%
C: -6.33%
global report cancer growth market
NTRA ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of June 27, 2022 in the Class Action Filed on Behalf of Natera, Inc. Shareholders
Published: 2022-05-17 (Crawled : 10:00) - prnewswire.com
NTRA S | $87.28 -3.38% -3.6% 1.2M
|
Health Services
|
| O: 2.39%
H: 5.7%
C: 5.56%
deadline
Natera Announces Publication Highlighting Importance of Testing Total cfDNA when Monitoring Kidney Transplant Patients with COVID-19 Infection
Published: 2022-04-01 (Crawled : 12:00) - prnewswire.com
NTRA S | $87.28 -3.38% -3.6% 1.2M
|
Health Services
|
| O: -0.02%
H: 5.7%
C: 5.48%
covid-19 kidney infection test infections
Natera Announces Q-Sub Filing with FDA for its Panorama® NIPT
Published: 2022-08-10 (Crawled : 23:00) - biospace.com/
NTRA S | $87.28 -3.38% -3.6% 1.2M
|
Health Services
|
| O: 3.29%
H: 6.84%
C: 5.33%
panorama fda
Natera to Participate in the Piper Sandler 34th Annual Healthcare Conference
Published: 2022-11-23 (Crawled : 14:00) - biospace.com/
NTRA S | $87.28 -3.38% -3.6% 1.2M
|
Health Services
|
| O: 0.17%
H: 7.02%
C: 4.93%
conference
Medicare Publishes Final Local Coverage Determination for Pan-Cancer Immunotherapy Monitoring with Natera's Signatera™ MRD Test
Published: 2021-11-11 (Crawled : 17:00) - prnewswire.com
NTRA S | $87.28 -3.38% -3.6% 1.2M
|
Health Services
|
| O: 1.0%
H: 5.18%
C: 4.76%
immunotherapy test therapy cancer
Natera Supports Updated ISHLT Guidelines for the Care of Heart Transplant Patients
Published: 2022-12-22 (Crawled : 13:00) - biospace.com/
NTRA S | $87.28 -3.38% -3.6% 1.2M
|
Health Services
|
| O: -1.73%
H: 4.73%
C: 4.68%
guidelines care heart
Natera Announces Real-World Data Collaboration with Merck
Published: 2023-11-14 (Crawled : 14:30) - biospace.com/
NTRA S | $87.28 -3.38% -3.6% 1.2M
|
Health Services
|
| O: 2.95%
H: 4.4%
C: 4.3%
merck collaboration
Symposium: Early experience with renal genetic testing in an internal medicine clinic
Published: 2021-05-13 (Crawled : 22:00) - natera.com
NTRA S | $87.28 -3.38% -3.6% 1.2M
|
Health Services
|
| O: 0.66%
H: 5.61%
C: 4.11%
genetic renal test symposium
Natera to Participate in the Cowen 41st Annual Health Care Conference
Published: 2021-02-23 (Crawled : 15:00) - biospace.com/
NTRA S | $87.28 -3.38% -3.6% 1.2M
|
Health Services
|
| O: -3.78%
H: 4.69%
C: 4.01%
health
Natera and BGI Genomics Announce Commercial Launch of the BGI/Natera Signatera Assay in China
Published: 2021-06-24 (Crawled : 13:15) - prnewswire.com
NTRA S | $87.28 -3.38% -3.6% 1.2M
|
Health Services
|
| O: 0.25%
H: 4.38%
C: 3.88%
china genomic commercialization
Natera Reports Second Quarter 2022 Financial Results
Published: 2022-08-04 (Crawled : 00:00) - biospace.com/
NTRA S | $87.28 -3.38% -3.6% 1.2M
|
Health Services
|
| O: 0.35%
H: 4.07%
C: 3.72%
results
Natera Announces New Study Highlighting the Benefits of Signatera’s Unique Method of Quantifying ctDNA
Published: 2023-12-21 (Crawled : 15:00) - biospace.com/
NTRA S | $87.28 -3.38% -3.6% 1.2M
|
Health Services
|
| O: 1.62%
H: 5.36%
C: 3.57%
unique study benefits
Natera and Tesis Labs Announce Strategic Collaboration on Prenatal Genetic Testing
Published: 2021-03-31 (Crawled : 13:15) - prnewswire.com
NTRA S | $87.28 -3.38% -3.6% 1.2M
|
Health Services
|
| O: 1.02%
H: 5.19%
C: 3.46%
genetic test collaboration
Gainers vs Losers
| 59% | 41% |
Top 10 Gainers
ZCMD | $1.45 5.84% 52.1% 2.3M
|
Commercial Services
TPET | $0.3279 -3.56% 28.48% 33M
|
n/a
GDHG | $0.263 21.76% 25.34% 1.3M
|
HOLO | $2.95 31.7% 22.49% 37M
|
UMAC | $1.55 0.65% 16.13% 3K
|
MTNB | $0.19 -1.04% 14.58% 950K
|
Health Technology
VLD 4 | $0.2638 -3.65% 13.27% 2.6M
|
Manufacturing
ALLR | $1.54 2.67% 11.76% 740K
|
n/a
MGLD 4 | $1.13 5.61% 10.62% 200
|
Manufacturing
NURO | $3.65 2.24% 10.3% 3.9K
|
Health Technology
Your saved searches
Save your searches and get alerts when important news are released.